Coagulation/Hemostasis Analyzers - Global Market Trajectory & Analytics

Global Coagulation/Hemostasis Analyzers Market to Reach $7 Billion by 2027

Amid the COVID-19 crisis, the global market for Coagulation/Hemostasis Analyzers estimated at US$3.9 Billion in the year 2020, is projected to reach a revised size of US$7 Billion by 2027, growing at a CAGR of 8.7% over the period 2020-2027. Clinical Laboratory Analyzers, one of the segments analyzed in the report, is projected to record 8.4% CAGR and reach US$5.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Point-of-Care Testing Analyzers segment is readjusted to a revised 10.3% CAGR for the next 7-year period.



The U.S. Market is Estimated at $1.1 Billion, While China is Forecast to Grow at 11.8% CAGR

The Coagulation/Hemostasis Analyzers market in the U.S. is estimated at US$1.1 Billion in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2027 trailing a CAGR of 11.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.9% and 7.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6.8% CAGR.

Select Competitors (Total 41 Featured):

• Alere, Inc.
• Diagnostica Stago SAS
• Helena Laboratories, Inc.
• Instrumentation Laboratory
• Nihon Kohden Corporation
• Roche Diagnostics (Schweiz) AG
• Siemens Healthineers
• Sysmex Corporation
• Thermo Fisher Scientific, Inc.